PHSC plc
04 July 2005
PHSC plc
Admission to AIM
PHSC plc ('PHSC' or the 'Company'), today announces that, with effect from
08.00am today (4 July 2005), its existing ordinary shares of 10p each
('Ordinary Shares') have been admitted to AIM. Ruegg & Co Limited is acting as
the nominated adviser and broker.
Words and expressions defined in the Admission Document published on 28 June
2005 shall have the same meaning as in this announcement.
Key Statistics
Number of Ordinary Shares in issue
immediately following Admission 9,785,504
Market Capitalisation of the Company at 64.5p per share
(being the mid-price as quoted on Ofex at close of business
on 27 June 2005) GBP6,311,650
The Company, through its three wholly-owned operating subsidiaries (being
PHSCL, RSA and ALS), is a provider of health, safety and environmental services
to corporate and public sector clients.
The revenues of PHSCL, now a wholly-owned subsidiary of the Company, were
£37,000 for the year ended 31 March 1992, which was the first full year of
trading. Revenues have demonstrated a consistent upward trend since then such
that the revenues of the Group, which now comprises a holding company, three
operating subsidiaries and four dormant subsidiaries, were £2,217,450 for the
year ended 31 March 2005. The pre-tax profit for the year was £476,112. Since
the year end the Company acquired ALS which for the ten month period to 28
February 2005 had revenues of £1,495,245 and reported pre-tax profits of
£332,790.
During 2004 the Company embarked upon a proactive acquisition strategy seeking
contracts or businesses within the health and safety consultancy sector. The
Company, which has its headquarters in Aylesford in Kent, was incorporated on
8 December 2000 and is the holding company of the Group. The Company's shares
were admitted to trading on Ofex on 3 June 2003, since when the Company has
acquired three businesses complementary to that of PHSCL.
- Ends -
For further information, please contact:
PHSC plc Ruegg & Co Limited
Stephen King Gavin Burnell
T: 01622 717700 T: 020 7584 3663
This information is provided by RNS
The company news service from the London Stock Exchange
EN
MSCILFIRDVILIIE
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.